This week on Contemporary OB/GYN®: Oct. 4 to Oct. 8
Here's what's coming up on Contemporary OB/GYN® this week.
You can expect a variety of topics to be covered this week, including:
Premature menopause shows significant link to cardiovascular disease
Premature menopause is significantly linked to eventual atherosclerotic cardiovascular disease (ASCVD), according to a research letter in JAMA Cardiology.
Ultrasound pain management device makes way for new FDA category
The US Food and Drug Administration created a new category for ZetrOZ's Acoustic Medicine device.
FDA approves Fortini™ formula for term infants with failure to thrive
The US Food and Drug Administration (FDA) has cleared Fortini™, a formula meant for the nutritional needs of term infants with failure to thrive.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
